Hematology Highlights with Dr Joshua Richter

Decera Clinical Insights
  • 0.0 (0)
  • Life Sciences
  • Updated Weekly

In this series, Dr Joshua Richter gives expert updates for clinicians who treat blood cancers.

Episodes

  1. Sep 28

    Hematology Highlights With Dr Joshua Richter: Episode 4: The Overlooked Step in CAR T Success

    In this episode, we return to our discussion on bridging therapy where Dr Joshua Richter walks through how to bet manage patients with multiple myeloma before CAR T-cell infusion, covering strategies to control disease, preserve T-cell fitness, and balance efficacy against toxicity so patients reach infusion safely. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Hematology Highlights With Dr Joshua Richter: Episode 4: The Overlooked Step in CAR T Success

  2. Aug 26

    Hematology Highlights With Dr Joshua Richter: Episode 3: Real-World Treatment Strategies for Older Adults with Multiple Myeloma: A Conversation with Dr Larysa Sanchez

    In this episode of Hematology Highlights, Dr Joshua Richter speaks with Dr Larysa Sanchez about real-world treatment considerations for older adults with relapsed or refractory multiple myeloma. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Hematology Highlights With Dr Joshua Richter: Episode 3: Real-World Treatment Strategies for Older Adults with Multiple Myeloma: A Conversation with Dr Larysa Sanchez

  3. Jul 30

    Hematology Highlights With Dr Joshua Richter: Episode 2: Treating Multiple Myeloma When T-Cell Redirection Is Not an Option

    Dr Joshua Richter reviews multiple myeloma treatment options for patients who are ineligible for or decline T-cell redirection therapy, including CAR T-cell therapy and bispecific antibodies. He discusses alternative therapies for relapsed or refractory multiple myeloma, including belantamab mafodotin, selinexor, venetoclax, cytotoxic chemotherapy, and emerging CELMoDs, with a focus on treatment sequencing, efficacy, and toxicity. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Hematology Highlights With Dr Joshua Richter: Episode 2: Treating Multiple Myeloma When T-Cell Redirection Is Not an Option

  4. Jun 30

    Hematology Highlights With Dr Joshua Richter: Episode 1: From Brain to Vein: Navigating the Road to CAR T-Cell Therapy

    In this inaugural episode of Hematology Unscripted, Dr Joshua Richter walks you through how to manage patients with multiple myeloma in the lead-up to CAR T-cell infusion, covering strategies to control disease, preserve T-cell fitness, and balance efficacy against toxicity so patients reach infusion safely. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Hematology Highlights With Dr Joshua Richter: Episode 1: From Brain to Vein: Navigating the Road to CAR T-Cell Therapy
  • 4 Episodes

About

In this series, Dr Joshua Richter gives expert updates for clinicians who treat blood cancers.

Information